Published in Biotech Business Week, November 29th, 2004
Total product sales for the third quarter were $12,141,000 compared with $11,927,000 reported for the same quarter last year and $12,024,000 reported for the second quarter of 2004. Excluding the impact of changes in currency, third quarter 2004 total product sales were $11,711,000.
Total product sales for the 9-month period ended October 1, 2004, were $37,733,000 compared with $37,656,000 reported for the comparable 9-month period of 2003. Total revenue for the 9-month period ended October 3, 2003, was $37,705,000, which...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.